479 related articles for article (PubMed ID: 8675157)
1. Biochemical epidemiology of gallbladder cancer.
Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the gallbladder in Bolivia: suggestions concerning etiology.
Rios-Dalenz J; Takabayashi A; Henson DE; Strom BL; Soloway RD
Am J Gastroenterol; 1985 May; 80(5):371-5. PubMed ID: 3993637
[TBL] [Abstract][Full Text] [Related]
3. Fecal bile acid excretion profile in gallstone patients.
Mamianetti A; Garrido D; Carducci CN; Vescina MC
Medicina (B Aires); 1999; 59(3):269-73. PubMed ID: 10451567
[TBL] [Abstract][Full Text] [Related]
4. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
[TBL] [Abstract][Full Text] [Related]
5. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
7. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
[TBL] [Abstract][Full Text] [Related]
8. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
9. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.
Azzaroli F; Mazzella G; Mazzeo C; Simoni P; Festi D; Colecchia A; Montagnani M; Martino C; Villanova N; Roda A; Roda E
Am J Gastroenterol; 1999 Sep; 94(9):2453-9. PubMed ID: 10484008
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
[TBL] [Abstract][Full Text] [Related]
11. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
[TBL] [Abstract][Full Text] [Related]
12. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
Salen G; Verga D; Batta AK; Tint GS; Shefer S
Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
[TBL] [Abstract][Full Text] [Related]
13. Role of bile bacteria in gallbladder carcinoma.
Sharma V; Chauhan VS; Nath G; Kumar A; Shukla VK
Hepatogastroenterology; 2007 Sep; 54(78):1622-5. PubMed ID: 18019679
[TBL] [Abstract][Full Text] [Related]
14. Bile acid pattern of gallbladder and hepatic bile in patients with and without cholesterol gallstones.
Arnesjö B; Bodvall B; Ståhl E
Acta Chir Scand; 1975; 141(2):135-8. PubMed ID: 1154966
[TBL] [Abstract][Full Text] [Related]
15. Disorders of bile acid metabolism in cholesterol gallstone disease.
Berr F; Pratschke E; Fischer S; Paumgartner G
J Clin Invest; 1992 Sep; 90(3):859-68. PubMed ID: 1522238
[TBL] [Abstract][Full Text] [Related]
16. Hemolysis-induced gallstones in mice: increased unconjugated bilirubin in hepatic bile predisposes to gallstone formation.
Trotman BW; Bernstein SE; Balistreri WF; Wirt GD; Martin RA
Gastroenterology; 1981 Aug; 81(2):232-6. PubMed ID: 7239131
[TBL] [Abstract][Full Text] [Related]
17. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
Stiehl A; Raedsch R; Kommerell B
Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
[TBL] [Abstract][Full Text] [Related]
18. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
19. Increased dietary fat content accelerates cholesterol gallstone formation in the cholesterol-fed prairie dog.
LaMorte WW; O'Leary DP; Booker ML; Scott TE
Hepatology; 1993 Dec; 18(6):1498-503. PubMed ID: 8244276
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones.
Kimura W; Shimada H; Kuroda A; Morioka Y
Am J Gastroenterol; 1989 Apr; 84(4):386-90. PubMed ID: 2929559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
